Inhibitory mechanisms of gabapentin, an antiseizure drug, on platelet aggregation

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 9, 2007, Pages 1255-1261

  Pan, Chi Feng ^a,b   Shen, Ming Yi ^a   Wu, Chih Jen ^b   Hsiao, George ^a   Chou, Duen Suey ^a   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CALCIUM; COLLAGEN; GABAPENTIN; INOSITOL; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; THROMBOXANE A2;

ANTICOAGULATION; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FREQUENCY MODULATOR; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; NORMAL HUMAN; PHOSPHORYLATION; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION;

AMINES; ANTICONVULSANTS; CALCIUM; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOBLOTTING; INOSITOL 1,4,5-TRISPHOSPHATE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; PLATELET AGGREGATION; THROMBOXANE A2; TYPE C PHOSPHOLIPASES;

EID: 34548433099     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.9.0010     Document Type: Article

References (25)

1. Attal, N., Brasseur, L., Parker, F., Chauvin, M., Bouhassira, D. (1998) Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur. J. Neurol. 40: 191-200
2. Bugaud, F., Nadal-Wollbold, F., Levy-Toledano, S., Rosa J. P., Bryckaert, M. (1999) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94: 3800-3805
3. Chesney, C. M., Pifer, D. D., Cagen, L. M. (1987) Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor to human platelets. Biochem. Biophys. Res. Commun. 144: 359-366
4. 2 cascade in hydroperoxide-stressed platelets. Free Radic. Biol. Med. 35: 616-625
5. Gu, Y. P., Huang, L. Y. (2001) Gabapentin actions on N-methyl-D aspartate receptor channels are protein kinase C-dependent. Pain 93: 85-92
6. Hass, W. K., Easton, J. D., Adams, H. P., Pryse-Philips, W., Molony, B. A., Anderson S., Kamm, B. A. (1989) Randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N. Engl. J. Med. 321: 501-507
7. Hsiao, G., Lin, K. H., Chang, Y., Chen, T. L., Tzu, N. H., Chou, D. S., Sheu, J. R. (2005) Protective mechanisms of inosine in platelet activation and cerebral ischemic damage. Arterioscler. Thromb. Vacs. Biol. 25: 1998-2004
8. Hughes, P. E., Renshaw, M. W., Pfaff, M., Forsyth, J., Keivens, V. M., Schwartz, M. A., Ginsberg, M. H. (1997) Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88: 521-530
9. Karaseva, T. L., Belikova, M. V., Pavlovskii, V. I., Andronati, K. S., Kabanova, T. A. (1998) In vitro effect of 1,2-dihydro-3H-1,4-benzodiazepine-2- one derivatives on the platelet aggregation and lipid peroxidation in rats. Ukr. Biokhim. Zhurnal. 70: 81-85
10. Magnus, L. (1999) Nonepileptic uses of gabapentin. Epilepsia 40: S66-S74
11. Mangin, P., Yuan, Y., Goncalves, I., Eckly, A., Freund, M., Cazenave, J. P., Gachet, C., Jackson, S. P., Lanza, F. (2003) Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. J. Biol. Chem. 278: 32880-32891
12. 2 mediates the stimulation of inositol 1,4,5-trisphosphate production and intracellular calcium mobilization by bradykinin in neonatal rat ventricular cardiomyocytes. Hypertension 28: 444-449
13. Ramsey, R. E. (1995) Gabapentin: toxicity. In: Levy RH, Mattson R. H., Meldrum B. S. (eds) Antiepileptic drugs. Raven Press, New York, pp 857-860
14. Rao, M. L., Clarenbach, P., Vahlensieck, M., Kratzschmer, S. (1988) Gabapentin augments whole blood serotonin in healthy young men. J. Neural. Transm. 73: 129-134
15. Rose, M. A., Kam, C. A. (2002) Gabapentin: pharmacology and its use in pain management. Anaesthesia 57: 451-462
16. Saklatvala, J., Rawlinson, L., Waller, R. J., Sarsfield, S., Lee, J. C., Morton, L. F., Barnes, M. J. Farndale, R. W. (1996) Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J. Biol. Chem. 271: 6586-6589
17. 2+ homeostasis at dendritic spines in hippocampal neurons. J. Neurosci. 25: 4587-4592
18. Satzinger, G. (1994) Antiepileptics from gamma-aminobutyric acid. Arzneimittelforschung 44: 261-266
19. Sheu, J. R., Teng, C. M., Huang, T. F. (1992) Triflavin, an RGD-containing antiplatelet peptide, binds to GP IIIa of ADP-stimulated platelets. Biochem. Biophys. Res. Commun. 189: 1236-1242
20. Sheu, J. R., Yen, M. H., Hung, W. C., Lee, Y. M., Su, C. H., Huang, T. F. (1997) Triflavin inhibits platelet-induced vasocontraction in deendothelialized aorta. Arterioscler. Thromb. Vasc. Biol. 17: 3461-3468
21. Sheu, J. R., Hung, W. C., Wu, C. H., Ma, M. C., Kan, Y. C., Lin, C. H., Lin, M. S., Luk, H. N., Yen, M. H. (1999) Reduction in lipopolysaccharide- induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation 99: 3056-3062
22. Sheu, J. R., Lee, C. R., Lin, C. H., Hsiao, G., Ko, W. C., Chen, Y. C., Yen, M. H. (2000) Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb. Haemost. 72: 617-621
23. Sheu, J. R., Hsiao, G., Luk, H. N., Chen, Y. W., Chen, T. L., Lee, L. W., Lin, C. H., Chou, D. S. (2002) Mechanisms involved in the antiplatelet activity of midazolam in human platelets. Anesthesiology 96: 651-658
24. Taylor, C. P. (1995) Gabapentin: mechanisms of action. In: Levy R. H., Mattson R. H., Meldrum B. S. (eds) Antiepileptic drugs. Raven Press, New York, pp 829-841
25. Vollmer, K. O., Anhut, H., Thomann, P., Wagner, F., Jahncken, D. (1989) Pharmacokinetic model and absolute bioavailability of the new anticonvulsant gabapentin. Adv. Epileptol. 17: 209-211